Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 1330Neoplasms 993Carcinoma, Non-Small-Cell Lung 859Prostatic Neoplasms 725Colorectal Neoplasms 666Lung Neoplasms 552Leukemia, Myeloid, Acute 473Neoplasm Metastasis 430Pancreatic Neoplasms 420Carcinoma, Hepatocellular 407Multiple Myeloma 394Ovarian Neoplasms 391Stomach Neoplasms 379Recurrence 368Squamous Cell Carcinoma of Head and Neck 326Melanoma 293Brain Neoplasms 287Uterine Cervical Neoplasms 283Triple Negative Breast Neoplasms 270Glioblastoma 263Head and Neck Neoplasms 261Precursor Cell Lymphoblastic Leukemia-Lymphoma 254Endometrial Neoplasms 233Lymphoma 229Rectal Neoplasms 225Esophageal Neoplasms 225Sarcoma 212Carcinoma, Renal Cell 203Colonic Neoplasms 195Lymphoma, Non-Hodgkin 192

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Interventional × Non-Malignant Neoplasm × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡